4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011489
Chief Medical Officer gave up 818 shares (to pay taxes)
- Chief Medical Officer acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2019-02-16 | Option exercise | +2,750 | 8,013 | D: show line 1 in the form | ||
| Bowden Christopher Chief Medical Officer | 2019-02-19 | Shares withheld for taxes | −818 | $58.03 | $47,469 | 7,195 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2019-02-16 | Option exercise · Restricted stock unit | −2,750 | 5,500 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…